Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
PUT
British American Tobacco
BTI
$123B
| $16.2M | ﹤0.01% |
376,600
-112,500
| -23% | -$4.83M |
|
2002
CALL
Ball Corp
BALL
$16.4B
| $16.2M | ﹤0.01% |
234,900
+130,500
| +125% | +$9.9M |
|
2003
JPMorgan BetaBuilders Canada ETF
BBCA
$11.4B
| $16.1M | ﹤0.01% |
274,599
+261,068
| +1,929% | +$16.9M |
|
2004
Trip.com Group
TCOM
$28.3B
| $16.1M | ﹤0.01% |
587,026
+482,723
| +463% | +$10.8M |
|
2005
PUT
US Global Jets ETF
JETS
$824M
| $16.1M | ﹤0.01% |
976,000
-250,800
| -20% | -$4.94M |
|
2006
PUT
Realty Income
O
$59.4B
| $16.1M | ﹤0.01% |
235,800
+13,560
| +6% | +$932K |
|
2007
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $16.1M | ﹤0.01% |
188,600
+85,500
| +83% | +$7.73M |
|
2008
CALL
Canadian Pacific Kansas City
CP
$82.2B
| $16M | ﹤0.01% |
229,552
+121,824
| +113% | +$8.82M |
|
2009
PUT
AMN Healthcare
AMN
$1.34B
| $16M | ﹤0.01% |
146,000
+49,500
| +51% | +$4.9M |
|
2010
CALL
W.P. Carey
WPC
$16.3B
| $16M | ﹤0.01% |
197,257
+152,027
| +336% | +$12.3M |
|
2011
CALL
Cadence Design Systems
CDNS
$89.5B
| $16M | ﹤0.01% |
106,600
+21,200
| +25% | +$3.2M |
|
2012
PUT
Old Dominion Freight Line
ODFL
$43.7B
| $16M | ﹤0.01% |
124,600
+6,400
| +5% | +$839K |
|
|
2013
CALL
Trip.com Group
TCOM
$28.3B
| $16M | ﹤0.01% |
581,600
-831,400
| -59% | -$18.6M |
|
2014
PUT
Emerson Electric
EMR
$91B
| $15.9M | ﹤0.01% |
200,100
-64,000
| -24% | -$5.64M |
|
2015
PUT
AB InBev
BUD
$157B
| $15.9M | ﹤0.01% |
294,500
+75,400
| +34% | +$4.23M |
|
|
VMEO
2016
DELISTED
Vimeo
VMEO
| $15.9M | ﹤0.01% |
2,636,049
+2,208,926
| +517% | +$20M |
|
2017
Eastern Bankshares
EBC
$5.4B
| $15.9M | ﹤0.01% |
858,957
+769,442
| +860% | +$14.9M |
|
2018
PUT
Synopsys
SNPS
$80.7B
| $15.9M | ﹤0.01% |
52,200
-97,900
| -65% | -$29.5M |
|
2019
CALL
Citizens Financial Group
CFG
$31.5B
| $15.8M | ﹤0.01% |
443,935
+175,535
| +65% | +$6.93M |
|
2020
Herc Holdings
HRI
$5.8B
| $15.8M | ﹤0.01% |
175,746
+164,965
| +1,530% | +$19.8M |
|
2021
Philip Morris
PM
$297B
| $15.8M | ﹤0.01% |
160,117
+11,714
| +8% | +$1.19M |
|
2022
Applied Materials
AMAT
$403B
| $15.8M | ﹤0.01% |
173,593
-86,486
| -33% | -$9.49M |
|
2023
BlackBerry
BB
$5.22B
| $15.8M | ﹤0.01% |
2,929,877
+1,966,326
| +204% | +$11.7M |
|
2024
CALL
Sanofi
SNY
$105B
| $15.8M | ﹤0.01% |
315,600
+46,100
| +17% | +$2.45M |
|
2025
Exponent
EXPO
$3.19B
| $15.8M | ﹤0.01% |
172,567
+149,528
| +649% | +$14.1M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.